 |
||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
|
|
|
||||||||||||||||||||||||||||||||||
|
|
|
 |
 |
 |
 |
|
 |
|
||||||
|
|
|
||||||||||||||
|
Staff |
|||||||||||||||||
Employment Opportunities |
||||||||||||||||||
|
Clinton
T. Rubin, Ph.D.
Dr. Rubin is also the Chair of the Department of Biomedical Engineering, which has developed a multidisciplinary graduate and undergraduate (bioengineering) program around the many faculty at the University and Brookhaven National Laboratories who are working on issues related to Biomedical Engineering and Biotechnology. Currently, there are over forty faculty involved in the program, and the areas of emphasis include biomechanics, biomaterials, medical imaging, computational modeling, bioprocessing, biotechnology and instrumentation. More specific information on the program, its goals, its faculty and students, can be collected via the homepage: www.bme.sunysb.edu Dr. Rubin's research interests focus on using biophysical stimuli (e.g., mechanical, electrical, temperature, acoustic), to accelerate the processes of wound healing and osseointegration, and as an intervention for osteoporosis. Dr. Rubin’s work is currently funded by NIH, NASA, the Whitaker Foundation, private industry and NYSTAR. Dr. Rubin holds five patents, with three pending, in the area of wound repair and treatment of bone disease. Finally, Dr. Rubin is a founder of a publicly traded medical device company (Exogen, Inc.). Related Links
for Clinton T. Rubin: Diane
Fabel
Ms. Judex holds key responsibility for the strategic planning, development and execution of the Center's Workforce Development Initiative statewide that effectively and efficiently address the needs of New York State bioscience industry. She serves as the Program Director for the Fundamentals of the Bioscience Industry program. Ms Judex’s outreach efforts will focus on establishing and enhancing the CAT’s relationships with academic and research institutions and regional and international bioscience industry organizations. She works closely with the Biotechnology Industry Organization (BIO) to direct the James D. Watson Helix Award, the bioscience industry’s sole award for outstanding corporate achievement, created by the CAT to recognize biotechnology companies that have distinguished themselves from its peers world over by setting a singular standard of corporate leadership reflected in performance in three areas of scientific innovation, company growth and corporate citizenship. She played a strategic role in the development of the Long Island Life Sciences Initiative (LILSI) and continues to provide guidance to LILSI on marketing strategies and regional workforce development initiatives. Ms Judex has more than 15 years of strategic planning, communications and management experience in both the corporate and non-profit sectors. Prior to joining the Center for Biotechnology, she held a variety of positions in corporate advertising at worldwide agencies, BBDO Canada and MacLaren McCann, overseeing regional and national accounts such as General Motors and Dairy Queen Canada and at a in-house corporate marketing department of a national sporting goods retailer. She has extensive experience in media relations, creative production management and strategic planning. She holds an MPA from Baruch College, NYC and a BA (Hons) Sociology from the University of Calgary, Canada. Joseph
Scaduto
Michael R. Bielski, J.D., M.S.
Melissa
Monaghan
Kate Posnanski Ms. Posnanski joined the Center for Biotechnology full-time in 2005. She received her B.A. in Communication from the University of Delaware and also holds a certification in Graphic Design from Hofstra University. Karin Bengtsson
Current employment opportunties at the Center:
back to top |
|
  |
Clinton
Rubin is Professor and Director of the 
Ms.
Fabel has primary responsibility for the financing and management of daily
operations, and has played a critical role in shaping the strategic direction
of the Center. She serves as a liaison between the bioscience industry,
the Center, and the academic community in the establishment of research
collaborations, new product development, company formations, and other
forms of economic impact. Her extensive experience in the development
of programs to support company start-ups is vital to the CAT's Technology
Development Initiative. Ms. Fabel played a strategic role in the development
of the New York Biotechnology Association and the Long Island High Technology
Incubator program. She received her M.S. degree in technology management
from SUNY Stony Brook.
Ms. Judex has responsibility for the planning and execution of the Center's
internal and external communication activities that will increase the
Center's profile and awareness to the bioscience industry, legislative,
academic and funding community. 
Mr.
Scaduto joins the Center as Business Development Manager. He received
his Masters in Biotechnology from Northwestern University and has a BS
in Biology from Binghamton University. He will be assisting in evaluating
the commercial potential of the technologies supported by the Center for
development and commercialization within New York State and in securing
research and development grants (SBIR, STTR, J2K). Mr. Scaduto is also
the part-time Executive Director of the Long Island Life Sciences Initiative
( LILSI). He will be responsible for developing the Initiative^s strategic
plan, nominating an active Board of Directors, and establishing contact
with executives from core industry members in order to identify corporate
needs and garner support for LILSI programs. Mr. Scaduto will manage the
operations of LILSI, implementing activities in Corporate Outreach, Legislative
Representation, Workforce Development, and Global Marketing of the life
sciences industry on Long Island.
Ms.
Melissa Monaghan joined the Center in March 2002 as Research Support Specialist
in the Applied Bioscience Laboratory (ABL). Ms. Monaghan received her
Bachelor of Science in Molecular Genetics from the University of Rochester,
Rochester, New York and her Master of Science in Microbiology and Immunology
from Albert Einstein College of Medicine, Bronx, New York. Her graduate
research was with HIV-1 reverse transcriptase where she gained experience
with numerous molecular and cell biology techniques, including recombinant
DNA, PCR, sequencing, protein expression, and tissue culture. Ms. Monaghan
conducts translational research with a broad range of commercially promising
biology-related technologies including research tools, diagnostics, or
therapeutics.